1. Home
  2. OABI vs BHST Comparison

OABI vs BHST Comparison

Compare OABI & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OABI
  • BHST
  • Stock Information
  • Founded
  • OABI 2012
  • BHST 2007
  • Country
  • OABI United States
  • BHST Canada
  • Employees
  • OABI 114
  • BHST N/A
  • Industry
  • OABI Biotechnology: Pharmaceutical Preparations
  • BHST
  • Sector
  • OABI Health Care
  • BHST
  • Exchange
  • OABI Nasdaq
  • BHST Nasdaq
  • Market Cap
  • OABI 239.0M
  • BHST 216.5M
  • IPO Year
  • OABI N/A
  • BHST N/A
  • Fundamental
  • Price
  • OABI $1.65
  • BHST $10.67
  • Analyst Decision
  • OABI Strong Buy
  • BHST Strong Buy
  • Analyst Count
  • OABI 3
  • BHST 2
  • Target Price
  • OABI $6.67
  • BHST $13.00
  • AVG Volume (30 Days)
  • OABI 525.9K
  • BHST 105.9K
  • Earning Date
  • OABI 11-04-2025
  • BHST 11-24-2025
  • Dividend Yield
  • OABI N/A
  • BHST N/A
  • EPS Growth
  • OABI N/A
  • BHST N/A
  • EPS
  • OABI N/A
  • BHST N/A
  • Revenue
  • OABI $23,027,000.00
  • BHST $30,192,000.00
  • Revenue This Year
  • OABI N/A
  • BHST $116.40
  • Revenue Next Year
  • OABI $48.74
  • BHST $55.91
  • P/E Ratio
  • OABI N/A
  • BHST N/A
  • Revenue Growth
  • OABI 6.05
  • BHST 57.83
  • 52 Week Low
  • OABI $1.22
  • BHST $4.66
  • 52 Week High
  • OABI $4.87
  • BHST $12.80
  • Technical
  • Relative Strength Index (RSI)
  • OABI 48.14
  • BHST 50.51
  • Support Level
  • OABI $1.64
  • BHST $10.20
  • Resistance Level
  • OABI $1.76
  • BHST $11.88
  • Average True Range (ATR)
  • OABI 0.10
  • BHST 1.37
  • MACD
  • OABI 0.01
  • BHST -0.14
  • Stochastic Oscillator
  • OABI 23.44
  • BHST 50.47

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: